CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN METASTASES
Bibliographic record
Abstract
It is now accepted that for patients with 1–4 brain metastases radiosurgery (SRS) provides improved cognitive and quality of life (QoL) outcomes vs. whole-brain radiotherapy (WBRT). It has been our recent finding that SRS also provides overall survival equivalent to WBRT following resection of a brain metastasis, again with improved cognitive and QoL outcomes. A gap in high-level evidence remains for patients with 5 or more brain metastases. We report on the framework of a Phase III trial. The NCI Brain Malignancies Steering Committee approved the trial concept in March 2017. The trial is to be led by the NCIC and endorsed by the NRG and Alliance for Clinical Trials in Oncology. Planned total accrual is 206 patients randomized to either radiosurgery (volume-based dosing) or WBRT (30Gy in 10 daily fractions) and memantine. Eligible patients will have a maximum total tumor volume of 30cm3. They will have 5–15 parenchymal metastases, free of gross leptomeningeal disease and ECOG performance status 0–2. The primary endpoints will be cognitive deterioration free survival and overall survival. Secondary endpoints include those related to: patient/treatment related outcomes (patterns of failure, validation of a nomogram to predict early appearance of new brain metastases, time to (re-)initiation of systemic therapy, etc.), economic endpoints (comparison based on payer rates (Medicare for US / provincial heath authorities in Canadian jurisdictions with activity-based funding) as well as comparison based on “time based activity costing” in selected institutions), dosimetric endpoints, imaging endpoints and quality of life endpoints. Translational endpoints will include analysis of serum samples to elucidate molecular/genomic mechanisms of neurocognitive decline. Additional translational endpoints are contingent on the outcome of applications for supplemental funding. A collaborative effort has been agreed upon to fill the largest evidence gaps in the focal management of brain metastases.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.009 | 0.021 |
| Meta-epidemiology (narrow) | 0.002 | 0.001 |
| Meta-epidemiology (broad) | 0.002 | 0.001 |
| Bibliometrics | 0.001 | 0.002 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.004 | 0.002 |
| Open science | 0.003 | 0.001 |
| Research integrity | 0.007 | 0.007 |
| Insufficient payload (model declined to judge) | 0.124 | 0.037 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".